- Home
- RGR vs XNCR Comparison
RGR vs XNCR Comparison
Compare RGR & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- XNCR
- Stock Information
- Founded
- RGR 1949
- XNCR 1997
- Country
- RGR United States
- XNCR United States
- Employees
- RGR N/A
- XNCR N/A
- Industry
- RGR Ordnance And Accessories
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- XNCR Health Care
- Exchange
- RGR Nasdaq
- XNCR Nasdaq
- Market Cap
- RGR 616.8M
- XNCR 579.3M
- IPO Year
- RGR N/A
- XNCR 2013
- Fundamental
- Price
- RGR $36.06
- XNCR $8.07
- Analyst Decision
- RGR
- XNCR Buy
- Analyst Count
- RGR 0
- XNCR 7
- Target Price
- RGR N/A
- XNCR $27.50
- AVG Volume (30 Days)
- RGR 207.4K
- XNCR 788.6K
- Earning Date
- RGR 07-30-2025
- XNCR 08-04-2025
- Dividend Yield
- RGR 1.94%
- XNCR N/A
- EPS Growth
- RGR N/A
- XNCR N/A
- EPS
- RGR 1.83
- XNCR N/A
- Revenue
- RGR $534,561,000.00
- XNCR $127,228,000.00
- Revenue This Year
- RGR N/A
- XNCR N/A
- Revenue Next Year
- RGR $1.89
- XNCR $28.84
- P/E Ratio
- RGR $19.66
- XNCR N/A
- Revenue Growth
- RGR 0.65
- XNCR N/A
- 52 Week Low
- RGR $32.74
- XNCR $7.16
- 52 Week High
- RGR $46.40
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- RGR 45.70
- XNCR 39.25
- Support Level
- RGR $35.53
- XNCR $7.88
- Resistance Level
- RGR $36.40
- XNCR $8.80
- Average True Range (ATR)
- RGR 0.73
- XNCR 0.49
- MACD
- RGR -0.12
- XNCR -0.09
- Stochastic Oscillator
- RGR 23.30
- XNCR 9.33
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.